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Abstract: Chitosan, a derivative of the
natural polysaccharide chitin, is known for its
biocompatibility and metal-binding capacity.
The aim of this study was to combine these
two properties of chitosan and investigate its
potential as a new iron (III) ion (ferric ion)
adsorbing agent. The development of a safe
and orally active iron chelating agent is
especially important for the treatment of
thalassemics.
In
this
study,
the
physicochemical parameters affecting the
ability of chitosan flakes to adsorb iron (III)
ions were studied by complexometric
titration. The results showed that the iron
(III) adsorption capacity of chitosan increases
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Introduction
Chitin is a natural polysaccharide obtained from crab
and shrimp shells or from similar sources. Chitosan is the
deacetylated form of chitin:

with the amount of chitosan, degree of
deacetylation of chitosan, concentration of
ferric ions in solution and with the pH of the
medium. The amount of ferric ions that
adsorb on the polymer increases with time
until an equilibrium is reached between
adsorbed iron (III) ions and those in solution.
Preliminary in vitro results obtained in
human blood serum indicate that chitosan is
capable of adsorbing iron (III) ions in the
body fluid medium and may be a suitable
iron-adsorbing agent in biological systems.
Key Words: chitin, chitosan, iron-chelation,
iron-adsorption, thalassemia.

The main advantage of chitosan over chitin is that it is
soluble in dilute acid solutions through protonation of
amine groups. Chitin and chitosan have a very diverse
range of applications such as in the food, textile and
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cosmetics industries in addition to environmental and
biomedical applications (1,2). Chitin and especially
chitosan have been used as bone and tooth filling
material, drug conjugates, microparticulate controlled
drug delivery systems and in enzyme immobilization
(2,3). The ability of chitosan to chelate metal ions both in
solution and in the solid state have been studied,
suggesting the possibility of using this polymer in wastewater treatment for environmental purposes (2,3).
However, no reports in the literature could be found on
any biomedical application of the ion-chelation capacity of
chitin or chitosan.

polymer is worth studying as an oral, parentral or
subcutaneuos iron-chelating agent if prepared in the form
of microspheres of dimensions of the order of 30 Ð 100
nm (5). There are applications and in vivo studies on oral
applications of chitosan as a dietary food (6), and as an
oral adsorbent for urea and ammonia (7,8,9). It may
prove to be an alternative to deferoxamine or deferiprone
when its chelation capacity, biocompatibility,
biodegradability and cost are considered. The toxicity of
chitosan and chitosan derivatives in living systems is still
being investigated (10, 11).

Iron overload in the human body may result in
damage in the heart, liver and other organs. Iron
overload is an especially important problem with
thalassemia patients who have to undergo blood
transfusions frequently. Beta-thalassemia, also called
CooleyÕs anaemia, thalassemia major, Mediterranean
Anemia or Hereditary Leptocytosis, is a type of blood
disorder characterized by a deficiency of hemoglobin, the
blood protein that transports oxygen to the tissues.
Thalassemia is caused by genetically determined
abnormalities in the synthesis of one or more the of
polypeptide chains that make up the globin part of
hemoglobin. Combined red blood cell transfusion and
iron-chelation therapy remains the primary treatment of
CooleyÕs anaemia. To prevent disability and death from
transfusional iron overload, daily prolonged intravenous
or subcutaneous infusions of the iron-chelating agent
deferoxamine are needed. Deferoxamine B mesylate
(Desferal), which is a very widely used iron-chelator was
first introduced in 1962. Although chelation therapy with
deferoxamine increased the life expectancy of
thalassemics to more than forty years, this therapy is very
demanding physically, psychologically and financially.
Recently, an orally active iron-chelating agent,
deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one, also
known as L1, CP20 and DMHP), has been introduced.
Clinical evaluation of this agent has provided evidence
that deferiprone is effective in decreasing body iron to a
tolerable level. However, some patients have developed a
life-threatening drop in their white cell counts
(neutropenia or agranulocytosis) during deferiprone
treatment (4).

Material and Methods

The development of a safe and orally active ironchelator still remains a major problem and is given
number one priority in Recommendations for Research
by the National Institutes of Health Ð National Heart,
Lung, and Blood Institute (4). Our in vitro study on
chitosan has given promising results, suggesting that the
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Chitin was purchased from Sigma. Chitin flakes were
cleansed of any proteins and lipids by treatment with 1.0
M NaOH solution for 3h at about 80°C and washing in
water. They were then digested for 12h in 1.0 M HCl
solution at room temperature. The alkali and acid
treatments were repeated twice and the chitin was
decolorized by refluxing in acetone (12). Sodium
hydroxide was from Merck, hydrochloric acid, iron (III)
nitrate and EDTA were from BDH, and hydrobromic acid
was from Analar. All these reagents were used without
any further purification.
Preparation of Chitosan: Chitin flakes were treated
for 1,2 and 3 hours with 47% NaOH solution at 110°C
under nitrogen atmosphere, and washed with water at
about 80°C to neutrality (12). Three chitosan samples
(C1, C2 and C3) with different fractions of deacetylated
units were obtained. The samples obtained had only
limited solubility in dilute acetic acid. Only about 40% of
sample C3 was soluble in dilute acetic acid.
Determination of Degree of Deacetylation:
Chitosan hydrobromide salts from the soluble fraction of
chitosan samples were prepared and the free amino
group contents were determined by direct titration with
standard 0.1 M NaOH solution (13). The deacetylation
percentages are given in Table 1. Sample C3 was found
to have a deacetylation value of 57% by this method.
However, in this study chitosan was used as a solid
sample which was composed of soluble and insoluble
fractions. Therefore, a solid state 13C CP/MAS NMR
spectrum of sample C3 was taken, which gave us a more
realistic deacetylation value equal to 73%. CP/MS NMR
spectrum of the sample was taken at a spinning rate of 8
kHz, with a repetition time of 3s and contact time of
1ms. The number of scans was 15 000. Line integrals
were normalized at the C-1 signal of chitosan at 105
ppm. The spectrum is shown in Figure 1. Carbonyl carbon
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Sample

Iron (III) Adsorption Capacities of Chitosan Samples ( mmol
Fe+3/g chitosan) in 50 mL,10 mM Fe+3 Solution at a pH of
1.8 and at 20¡C at Different Contact Hours.

DD (%)

3 hours

6 hours

72 hours

40
50
57

0.276
0.534
0.552

0.537
1.24
1.27

0.673
1.53
1.54

C1
C2
C3

(C1, C2 and C3) and 100 ml samples of aqueous 10 mM
Fe (NO3)3.9H2O solution of pH 1.8 to the reaction flasks
thermostatically maintained at 20 ±0.5°C. After 3, 6 and
72 hours, the mixtures were filtered, treated with 10%
sodium acetate solution to attain a pH of 2-3 and 2%
sulfosalicylic acid was added as indicator to form the
violet-red complex. The solution was then heated to 4050°C and the amount of Fe+3 ions remaining in solution
was determined by titration with 0.1 M EDTA solution
(15). Then the amount of adsorbed ions was calculated by
subtracting the amount of Fe+3 ions from the initial
amount.

and methyl carbons of the N-acetyl group appear at 174
ppm and 24 ppm respectively. The peaks at 106, 84, 76,
60 and 56 ppm belong to C-1, C-4, C-5 and C-3, C-6 and
C-2 carbons of the pyranose ring of chitosan respectively.

In a second set of experiments, the effects of the
concentration of Fe+3 ions in solution and pH on the
amount of adsorbed ions onto chitosan were investigated.
The same procedure described above was repeated using
50 mg of samples of C3 and 100 mL, 1mM and 0.5 mM
solutions of Fe+3 with pH values of 3, 5 and 7 adjusted
with sodium acetate solution. EDTA solution at a
concentration of 0.01 M was used as the titrant. No
precipitation of Fe+3 ions in any form was observed under
the conditions mentioned above within the time interval
used for the adsorption profiles. Each experiment was
repeated twice and the results for each sample agreed
with each other within +/- 5% error.

Determination of Molar Mass of Chitosan: Dilute
solution viscometry with a home- made Ubbelohde-type
viscometer was used to determine the viscosity average
molar mass of the soluble fraction of chitosan, sample C3,
according to the method of Terbojevich and Cosani (14),
who reported K and a values at 25°C as 3.2*10-4 and
0.76 in 0.5M acetic acid/ 0.2M sodium acetate solution.
The Mv of the soluble fraction was calculated as 1.24*104
g/mol.

0.17

Figure 1.

13C

—

—

—

—

140

—

160

Determination of Adsorbed Iron in Human Blood:
Preliminary in vitro studies of normal human blood and

—

—

180

—

—

Determination of Adsorbed Iron: The effect of the
degree of deacetylation of chitosan flakes on the amount
of adsorbed iron was determined by adding 285 mg of
the chitosan samples of different degrees of deacetylation
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4.97

—

Table 1.

ppm
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CP/MAS spectrum of chitosan (C3).
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of thalassemia patientsÕ blood were carried out. Sample
C3, in the form of a flake, was brought into contact with
the above mentioned blood samples for 3 hours at 37°C.
The blood samples were analyzed for their iron content
by using an Irma-mat Ferritin test kit. 300 µl of Iodine125 Ðanti-ferritin agent was added to 25µl of sample
from the patient pipetted into a tube, and incubated for
2 hours at room temperature on a horizontal shaker. The
liquid was aspirated and the tubes washed with 2 ml of
0.9% NaCl solution. The radioactivity was measured
(CPM) using a Cap-Ria 16 multi channel gamma counter
by Capintec Inc. The validity and precision of the results
were checked with the control sample included with the
kit.

the chitosan surface. Hydroxyl groups and carbonyl
groups may also take part in the process in cooperation
with amino groups. Different mechanisms for the
interaction of metal ions with chitosan solutions involving
amine and hydroxyl groups have been proposed (16,17).
It can be seen that the amount of iron adsorbed increases
in time for all the samples studied. Since sample C3
produced the best result, further studies were carried out
with this sample only. The behavior of sample C3 under
the conditions above is shown in Figure 2. The amount of
adsorbed iron(III) ions increases with time, almost
reaching equilibrium within 6 hours.
The effects of time, pH and concentration of ferric
ions in the medium on the amount of iron adsorbed were
studied. The results obtained at pH=3, pH=5 and pH=7
at 20°C, in 10mM, 1mM and 0.5 mM ferric ion solutions
using 50.0 mg C3 sample in each experiment are
summarized in Figures 3, 4 and 5. The amount of iron
adsorbed on chitosan increases with time reaching
equilibrium at around 5 hours. At all the ferric ion
concentrations studied, increasing pH resulted in an
increase in the amount of adsorbed ferric ions.

Results and Discussion
Analysis of Iron-Adsorption Capacity of Chitosan
The adsorption of Fe+3 ions on the surface of insoluble
chitosan particles takes place as the formation of a
surface complex which involves nitrogen and oxygen
atoms in the repeat unit of chitosan:
CHI- NH2 + Fe+3 ⇔ [CHI- NH2---Fe---]+3

Figure 6 shows that there is a linear relationship
between pH of the medium and the amount of the
adsorbed iron (III) ions. The increasing pH of the medium
decreases the probability of having any soluble fraction of
chitosan in the medium with protonated amino groups.
As the fraction of free, unprotonated amino groups
increases, the number of nitrogen atoms with free
electrons increases in the medium. The sites available for
complexation with ferric ions increase in the medium and

(1)

The effects of time and degree of deacetylation on
iron-adsorption capacities of chitosan samples C1, C2 and
C3 in mmol Fe+3/g chitosan are compared in the Table 1.
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Ñ

Ñ

Ñ

1.5

Ñ
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The adsorption capacity at a pH of 1.8 at 20°C in a
ferric ion solution of concentration 10mM increases with
the degree of deacetylation of chitosan, indicating that
free amino groups take part in binding the Fe+3 ions onto
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Adsorption equilibrium of
iron (III) ions by Chitosan in
10 mM Fe+3 solution at 20
¡C and pH=1.8.

Adsorbed iron (mmol/g chitosan)
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this is reflected in an enhanced adsorption of ferric ions
onto chitosan. Another factor that may have an effect on
the increase in ferric ion adsorption with pH may be the
increasing tendency of iron (III) ions to separate from the
solution.
Figure 7 shows that the amount of adsorbed iron (III)
increases as the equilibrium concentration of iron (III)
ions in solution increases. This behavior can be explained
with equation (1), which represents the adsorption of the
ions on the polymer surface as an equilibrium reaction.
Equation (1) also explains why adsorption is parallel with
the degree of deacetylation of chitosan.

Figure 3.

Adsorption equilibria of
iron (III) ions by chitosan
in 10 mM Fe+3 solution
at 20¡C at pH = (◆: 7,
■: 5, ▲: 3 ).

Figure 4.

Adsorption equilibria of
iron (III) ions by chitosan
in 1 mM Fe+3 solution at
20¡C at pH = (◆: 7, ■:
5, ▲: 3 ).

It is also worth noting that the adsorption capacity of
chitosan increases when greater amounts of chitosan are
present in a given volume of the adsorption medium. This
is also due to the increase in the amount of free amino
groups in the adsorption medium. When 50 mg of
chitosan is placed in a 10 mM Fe+3 solution at a pH of 1.8,
after 5 hours the maximum adsorption capacity is 0.075
mmol Fe+3/g chitosan (Figure 6). When 285 mg chitosan
is used under the same conditions as shown in Figure 1,
the adsorption capacity of the polymer increases to about
0.75 mmol Fe+3/g chitosan. The ferric ion adsorption
capacity of the currently used chelating agent Desferal is
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Figure 5.

Adsorption equilibria of
iron (III) ions by chitosan
in 0.5 mM Fe+3 solution
at 20¡C at pH = (◆: 7,
■: 5, ▲: 3 ).

Figure 6.

Adsorption behavior of
iron (III) ions onto
chitosan with pH at
20¡C in 5 hours in 10
mM Fe+3 solution.

pH

reported as 8.5 mg iron/100 mg Desferal theoretically.
This is 1.5 mmol iron/g Desferal. Then, it is obvious that
chitosan is comparable to Desferal in terms of its iron
chelation capability.
Analysis of Iron-Adsorption Capacity of Chitosan in
Human Blood
In light of the analysis given above, preliminary in
vitro studies were carried out using human blood. In
3.0mL normal human blood of iron content, 40 µg/dL
chitosan flakes, (20.0 mg) adsorbed 3 µg/dL of Fe+3. The
new iron content of the blood serum was determined as
37 µg/dL after being in contact with chitosan (C3) for 3
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hours. However, when 20.0 mg C3 samples were
brought into contact with the blood serum of a
thalassemia patient with iron contents of 5795 µg/dL,
which may be taken to be equivalent to a 1 mM iron (III)
solution, it resulted in a decrease in the iron content of
the blood serum equivalent to 620 µg/dL. If interpreted
in terms of mmol iron (III) adsorbed/g chitosan, these
results correspond to 0.55 mmol Fe+3/g chitosan. This
value is promising when compared to the iron binding
capacity of Desferal, which is 1.5 mmol Fe+3/g Desferal.
The results obtained in human blood are in agreement
with the results obtained in the chemistry laboratory. In
a medium of high Fe+3 content, i.e. in the blood of
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Adsorbed iron (mmol/g chitosan)

Figure 7.
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Iron (III) adsorption
isotherm
for
iron
(III)/chitosan system at
pH=7, at 20¡C in 5
hours.

Fe (III) at equilibrium (mM)

thalassemia patients, the adsorption capacity of chitosan
is much higher than in a medium of low Fe+3 content, in
normal blood.
Since chitosan has an iron binding capacity that is
comparable with that of Desferal, it is worthwhile
investigating the potential of chitosan as an oral,
parentral or subcutaneous iron adsorbing agent. Factors
that might affect the iron adsorption capacity of chitosan
such as the particle size, molecular weight and physical
form are still under investigation. Microspheres of
chitosan will be tested for their iron adsorption capacities

in the near future. In addition, studies of human blood
will be carried out to see if chitosan has any adverse
effects on the composition of blood when its cholesterol,
metal ion and protein binding capacities are known.
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